Akèy › Miasteni grav › Texas › Dallas
Etid klinik pou Miasteni grav nan Dallas, TX
6 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Texas Neurology, Dallas
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Ap rekriteFaz 3
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Site Number - 1003, Dallas
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Ap rekriteFaz 3
- University of Texas Southwestern Medical Center, Dallas
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Ap rekriteFaz 1
- UT Southwestern Medical Center, Dallas
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Ap rekriteEtid obsèvasyon
- Clinical Trial Site, Dallas
Etid Miasteni grav nan lòt vil
- Tampa, FL12 etid
- Houston, TX11 etid
- Durham, NC10 etid
- Boca Raton, FL10 etid
- Columbus, OH8 etid
- Milwaukee, WI7 etid
- St. Louis, MO7 etid
- New York City, NY7 etid
- Miami, FL7 etid
- Jacksonville, FL6 etid
- Chattanooga, TN6 etid
- Boston, MA6 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.